Browse studies

Find your next paid study

1 recruiting study matching your filters

Phase II Study of Pembrolizumab in Combination With BCG After Endoscopic Ablation for Patients With High Risk Superficial Upper Urinary Tract Transitional Cell Carcinoma Unfit or Unwilling to be Treated With Nephroureterectomy

PURPOSE: This study is being conducted to test the safety of the study drug Pembrolizumab, also known as MK-3475, at different dose levels in combination with …

High Risk Superficial Upper Urinary Tract Transitional Cell CarcinomaEndoscopic Surgical ProcedureTransitional Epithelial Cells

Estimated

~$10 – $7,500

Shaheen AlaneeNCT03345134